PE79899A1 - DERIVATIVES OF 9-OXYME ERYTHROMYCIN - Google Patents

DERIVATIVES OF 9-OXYME ERYTHROMYCIN

Info

Publication number
PE79899A1
PE79899A1 PE1998000470A PE00047098A PE79899A1 PE 79899 A1 PE79899 A1 PE 79899A1 PE 1998000470 A PE1998000470 A PE 1998000470A PE 00047098 A PE00047098 A PE 00047098A PE 79899 A1 PE79899 A1 PE 79899A1
Authority
PE
Peru
Prior art keywords
alkyl
replaced
alcanoyl
cr7r8
optionally replaced
Prior art date
Application number
PE1998000470A
Other languages
Spanish (es)
Inventor
Yong-Jin Wu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE79899A1 publication Critical patent/PE79899A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA (I), X ES -CR7R8- o -NR7-; X JUNTO CON R2 FORMA -N=CR4R5; X Y R2 FORMAN JUNTOS UN HETEROCICLO DE FORMULA (XVI), DONDE r Y p SON 1-3; q ES 0-1 Y X1 ES -CH2-, O, S, -C(O)-, ENTRE OTROS; (CH2)r, (CH2)p; X1 ES -NH- ESTA OPCIONALMENTE SUSTITUIDA POR -C(O)O(ALQUILO C1-C10), ALCANOILO C1-C10, ENTRE OTROS; R1 ES H o ALQUILO C1-C10, REEMPLAZADO CON 1-3 O, S o N, OPCIONALMENTE SUSTITUIDO CON 1-3 -C(O)O(ALQUILO C1-C10), -NR7R8, S(O)n(ALQUILO C1-C10), n ES 0-2; R2 ES (i) H, R4, -C(O)R4, ENTRE OTROS CUANDO X ES -NR7-; (ii) H, R4 o -(CR7R8)mR3, CUANDO X ES -CR7R8-, m ES 0-6, R3 ES ARILO C6-C10 o UN HETEROCICLO DE 5-10 MIEMBROS OPCIONALMENTE SUSTITUIDOS POR 1-3 -C(O)O(ALQUILO C1-C10), ALCANOILO C1-C10, ENTRE OTROS; R4 Y R5 SON H Y ALQUILO C1-C12 OPCIONALMENTE REEMPLAZADOS POR O, S Y N Y SUSTITUIDO CON 1-3 -C(O)O(ALQUILO C1-C10), ALCOXI C1-C10, HALOGENO; R6 ES H, -C(O)R3 O ALCANOILO C1-C18 OPCIONALMENTE REEMPLAZADO POR O, S Y N; Y CADA R7 Y R8 SON H o ALQUILO C1-C6. UN COMPUESTO PREFERIDO ES 11,12-CARBAMATO DE 9-DESOXO-11-DESOXI-5-O-DESOSAMINIL-11-(3-(4-PIRIDIN-3-IL-IMIDAZOL-1-IL)-PROPIL)HIDRAZO-9-HIDROXIIMINO-6-O-METIL-3-OXOERITRONOLIDA A, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I PUEDE SER UTIL PARA TRATAR UNA INFECCION BACTERIANA O PROTOZOARIAREFERS TO A COMPOUND OF FORMULA (I), X IS -CR7R8- or -NR7-; X TOGETHER WITH R2 FORM -N = CR4R5; X AND R2 TOGETHER TOGETHER A HETERO-CYCLE OF FORMULA (XVI), WHERE r AND p ARE 1-3; q IS 0-1 AND X1 IS -CH2-, O, S, -C (O) -, AMONG OTHERS; (CH2) r, (CH2) p; X1 IS -NH- IS OPTIONALLY REPLACED BY -C (O) O (C1-C10 ALKYL), C1-C10 ALCANOYL, AMONG OTHERS; R1 IS H or C1-C10 ALKYL, REPLACED WITH 1-3 O, S or N, OPTIONALLY REPLACED WITH 1-3 -C (O) O (C1-C10 ALKYL), -NR7R8, S (O) n (C1 RENT -C10), n ES 0-2; R2 IS (i) H, R4, -C (O) R4, AMONG OTHERS WHEN X IS -NR7-; (ii) H, R4 or - (CR7R8) mR3, WHEN X IS -CR7R8-, m IS 0-6, R3 IS ARYL C6-C10 or A HETEROCICLE OF 5-10 MEMBERS OPTIONALLY SUBSTITUTED BY 1-3 -C (OR ) OR (C1-C10 ALKYL), C1-C10 ALCANOYL, AMONG OTHERS; R4 AND R5 ARE H AND C1-C12 ALKYL OPTIONALLY REPLACED BY O, S AND N AND REPLACED WITH 1-3-C (O) O (C1-C10 ALKYL), ALCOXI C1-C10, HALOGEN; R6 IS H, -C (O) R3 OR C1-C18 ALCANOYL OPTIONALLY REPLACED BY O, S AND N; AND EACH R7 AND R8 ARE H or ALKYL C1-C6. A PREFERRED COMPOUND IS 11,12-9-DESOXO-11-DESOXI-5-O-DESOSAMINIL-11- (3- (4-PIRIDIN-3-IL-IMIDAZOL-1-IL) -PROPIL) HYDRAZO-9 -HYDROXYIMINO-6-O-METHYL-3-OXOERITRONOLIDE A, AMONG OTHERS. IT ALSO REFERS TO A PROCEDURE FOR PREPARATION. COMPOUND I MAY BE USEFUL FOR TREATING A BACTERIAL OR PROTOZOARY INFECTION

PE1998000470A 1997-06-11 1998-06-08 DERIVATIVES OF 9-OXYME ERYTHROMYCIN PE79899A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
PE79899A1 true PE79899A1 (en) 1999-08-25

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000470A PE79899A1 (en) 1997-06-11 1998-06-08 DERIVATIVES OF 9-OXYME ERYTHROMYCIN

Country Status (31)

Country Link
EP (1) EP0988308A1 (en)
JP (1) JP2000513026A (en)
KR (1) KR20010013660A (en)
CN (1) CN1259135A (en)
AP (1) AP9801253A0 (en)
AR (1) AR012244A1 (en)
AU (1) AU7226798A (en)
BG (1) BG103947A (en)
BR (1) BR9810021A (en)
CA (1) CA2293335A1 (en)
CO (1) CO4940506A1 (en)
CZ (1) CZ9904388A3 (en)
EA (1) EA199901016A1 (en)
GT (1) GT199800074A (en)
HN (1) HN1998000073A (en)
HR (1) HRP980316A2 (en)
HU (1) HUP0002252A3 (en)
ID (1) ID24529A (en)
IL (1) IL132767A0 (en)
IS (1) IS5251A (en)
MA (1) MA26505A1 (en)
NO (1) NO996108L (en)
OA (1) OA11225A (en)
PA (1) PA8451801A1 (en)
PE (1) PE79899A1 (en)
PL (1) PL337606A1 (en)
TN (1) TNSN98083A1 (en)
TR (1) TR199902995T2 (en)
TW (1) TW448174B (en)
WO (1) WO1998056800A1 (en)
ZA (1) ZA985018B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (en) * 1997-10-29 1999-02-09 Monsanto Co DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA
WO2000017218A1 (en) 1998-09-22 2000-03-30 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (en) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
WO2000063224A2 (en) * 1999-04-16 2000-10-26 Kosan Biosciences, Inc. Macrolide antiinfective agents
IL145739A0 (en) 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
ES2208334T3 (en) * 1999-06-07 2004-06-16 Abbott Laboratories CETOLIDE DERIVATIVES OF 6-0 CARBAMATE.
ID27331A (en) * 1999-09-29 2001-03-29 Pfizer Prod Inc MAKING ANTIBIOTIC-ANTIBIOTIC KETOLIDA CARBAMATE
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
AR043050A1 (en) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
CN102816194A (en) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 Macrocyclic compounds and methods of making and using the same
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN102245195B (en) 2008-10-24 2016-01-13 森普拉制药公司 Use the biophylaxis of the macrolide containing triazole
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
CN102146085B (en) * 2010-02-09 2014-03-26 北京理工大学 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof
WO2011119604A1 (en) 2010-03-22 2011-09-29 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
AU2011255464C1 (en) 2010-05-20 2017-02-23 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc Hydrogen bond forming fluoro ketolides for treating diseases
EP2830632A4 (en) 2012-03-27 2015-10-21 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (en) * 1994-04-08 1997-01-10 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.

Also Published As

Publication number Publication date
CN1259135A (en) 2000-07-05
IL132767A0 (en) 2001-03-19
HUP0002252A3 (en) 2002-01-28
AU7226798A (en) 1998-12-30
GT199800074A (en) 1999-11-27
CO4940506A1 (en) 2000-07-24
HRP980316A2 (en) 1999-04-30
CA2293335A1 (en) 1998-12-17
BR9810021A (en) 2000-09-19
CZ9904388A3 (en) 2002-10-16
AP9801253A0 (en) 1999-12-04
TW448174B (en) 2001-08-01
MA26505A1 (en) 2004-12-20
WO1998056800A1 (en) 1998-12-17
EA199901016A1 (en) 2000-06-26
NO996108D0 (en) 1999-12-10
AR012244A1 (en) 2000-09-27
HN1998000073A (en) 1999-01-08
KR20010013660A (en) 2001-02-26
TR199902995T2 (en) 2000-02-21
NO996108L (en) 2000-02-10
ID24529A (en) 2000-07-20
TNSN98083A1 (en) 2005-03-15
PL337606A1 (en) 2000-08-28
ZA985018B (en) 1999-12-10
BG103947A (en) 2000-07-31
IS5251A (en) 1999-11-16
PA8451801A1 (en) 2000-05-24
OA11225A (en) 2003-07-17
JP2000513026A (en) 2000-10-03
HUP0002252A2 (en) 2000-12-28
EP0988308A1 (en) 2000-03-29

Similar Documents

Publication Publication Date Title
PE79899A1 (en) DERIVATIVES OF 9-OXYME ERYTHROMYCIN
PE122499A1 (en) DERIVATIVES OF 9-AMINO-3-KETO Erythromycin
PE79699A1 (en) DERIVATIVES OF 9-DESOXO-9A-AZA-9A-HOMOERITROMICINA A C-4 "SUBSTITUTED
PE79999A1 (en) DERIVATIVES OF MACROLIDES C-4 "SUBSTITUTED
RU97108157A (en) ANTIMICROBIAL PHENYLOXAZOLIDINONES
ATE217623T1 (en) AZINDOLETHYLAMINE DERIVATIVES AS NICOTINE-ACETYLCHOLINE RECEPTOR BINDING COMPOUNDS
PE46899A1 (en) N-PHENYL-SULFONAMIDE DERIVATIVES
FR2619111B1 (en) (PIPERIDINYL-4) METHYL-2 TETRAHYDRO-1,2,3,4 9H-PYRIDO (3,4-B) INDOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
DK334480A (en) PROCEDURE FOR PREPARING PHENOXYPIPERIDE INGREDIATES
NO924783D0 (en) THERAPEUTIC AGENTS
NO996453L (en) New tricyclic compounds with saturated rings, as well as medical mixtures containing the compounds
NZ503897A (en) 3,6-hemiketals from the class of 9a-azalides
DE69024778T2 (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their therapeutic use
PE122399A1 (en) TRICYCLIC ERYTHROMYCINE DERIVATIVES
ATE70274T1 (en) SUBSTITUTED 1,8-NAPHTHYRIDINE DERIVATIVES AND FUNGICIDES CONTAINING THEM.
KR880005927A (en) Uses of Carboxylic Acid Amides
FR2617476B1 (en) NOVEL AROMATIC POLYCYCLIC DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN AND VETERINARY MEDICINE AND IN COSMETICS
ES2059595T3 (en) BETA-CARBONYL-CARBOXYAMIDES 1,3-THIAZOLIDINES.
DK47688A (en) 5- (3-ALKYL-5-TERT.BUTYL-4-HYDROXYPHENYL) -2-AMINO-6H-1,3,4-THIADIAZINES, THEIR PREPARATION AND USE AS A MEDICINE
ES2102871T3 (en) ANTIPARASITIC AGENTS.
ES2087463T3 (en) BENZO (B) THIOFEN-2-CARBOXAMIDES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS.
ES555030A0 (en) PROCEDURE FOR THE OBTAINING OF NEW ISOXAZOL DERIVATIVES
ATE210135T1 (en) ANTIALLERGIC THIADIAZOLO(4,3-A)PYRIDINE DERIVATIVE
DK0894805T3 (en) Novel Ribose Substituted Aromatic Derivatives, Methods of Preparation thereof and Their Use as Antibiotic Medicines
BR9406818A (en) Benzopyrans as calcium channel opening agents

Legal Events

Date Code Title Description
FC Refusal